Simmaron is raising funds for studies to scientifically redefine ME/CFS. Your contributions will expand our ability to execute the strong scientific leads we have.
Data Extraction Studies
Simmaron has unparalleled data from clinical experience monitoring immune testing and utilizing immune-based treatments. We seek funding to extract and statistically analyze clinical experience with treatments, such as Ampligen, to publish data that will stimulate more clinical trials in ME/CFS.
Collaborators: Sierra Internal Medicine.
Cost: $100,000 for 2015-2016.
Assessment of the Prevalence of Clonal T-cell Receptor Gamma Gene Rearrangements in CFS Patients with Herpes Virus Infections
Simmaron will assess the diagnostic and prognostic potential value of analyzing CFS/ME patients for T-cell receptor gamma clonality. As CFS/ME is associated with increased incidence of lymphoma and certain other cancers, this study will investigate the value of T-cell gene rearrangements in identifying a subset of patients who are at risk of developing cancer, for diagnostic and treatment purposes.
Collaborators: University of Nevada, Reno, Sierra Internal Medicine.
Donate as we scientifically redefine ME/CFS!
*Simmaron Research supports 10% indirect costs in funded projects.